SDYX news

Latest 1 stories · newest Jun 10, 2026

SDYX

Syndax Pharmaceuticals issues $2.25% convertible senior notes due 2031

Syndax Pharmaceuticals entered into an indenture agreement with U.S. Bank Trust Company for convertible senior notes with a 2.25% interest rate maturing in 2031. This debt offering provides capital financing for the biopharmaceutical company's operations and development initiatives.

Offering Jun 10, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same SDYX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/SDYX/newsSTART FREE